VRXA
Veraxa Biotech Holding AG
There isn't enough reported data to score VRXA yet.
VRXA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate VRXA's fundamentals.
VRXA PE Valuation
VRXA has no meaningful PE right now: it lost money over the past year.
VRXA Forward outlook
There aren't enough analyst estimates for VRXA to show an outlook.
VRXA Earnings Per Share
VRXA Quarterly Revenue
VRXA Free Cash Flow
VRXA Net Leverage
VRXA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
VRXA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.4 | Oversold |
| Stochastic | 13.8 | Oversold |
VRXA's weekly RSI is 29 (oversold) and its Stochastic is 14 (oversold).
VRXA PE vs Healthcare Sector
VRXA has no meaningful PE right now: it lost money over the past year.
VRXA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.14 | 0.9% above |
| 20 week MA | $1.56 | 26% below |
VRXA has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 26% below its 20-week average.
VRXA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $10.4 | $1.15 | -89% |
It's down 89% so far in 2026.